NBM-BMX Capsule

DRUG2 trials

Sponsors

Novelwise Pharmaceutical Corporation

Conditions

Malignant NeoplasmMalignant Neoplasm of Brain

Phase 1

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

RecruitingNCT06012695

Novelwise Pharmaceutical CorporationMalignant Neoplasm, Malignant Neoplasm of Brain

Start: 2023-08-11End: 2029-09-30Target: 79Updated: 2026-04-29

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

RecruitingNCT07569042

Novelwise Pharmaceutical CorporationMalignant Neoplasm of Brain

Start: 2026-04-20End: 2030-12-31Target: 15Updated: 2026-05-06